Overall, these findings suggest that TGF-β-3 expression plays a crucial role in tumor progression and patient survival, whereas TGF-β-1 exhibits a weaker, albeit negative, influence on survival outcomes. The gene discussed is TGFB1; the disease is neoplasm.